Exopolysaccharide Producing Bifidobacterium animalis subsp. lactis Strains Modify the Intestinal Microbiota and the Plasmatic Cytokine Levels of BALB/c Mice According to the Type of Polymer Synthesized
Metadatos
Mostrar el registro completo del ítemAutor
Sabater, Carlos; Molinero-García, Natalia; Castro-Bravo, Nuria; Diez-Echave, Patricia; Hidalgo García, Laura; Delgado, Susana; Sánchez, Borja; Gálvez Peralta, Julio Juan; Margolles, Abelardo; Ruas Madiedo, PatriciaEditorial
Frontiers Media
Materia
exopolysaccharide bifidobacteria microbiota
Fecha
2020-11-26Referencia bibliográfica
Sabater, C. et. al. Front. Microbiol. 11:601233. [https://doi.org/10.3389/fmicb.2020.601233]
Patrocinador
Projects AGL2015- 64901-R (AEI/FEDER, UE) and RTI2018-096339-B-I00 (MCIU/AEI/FEDER, UE); Grant IDI/2018/000236 from the “Plan for Research, Development and Innovation of the Principado de Asturias 2018–2020” co-financed by the European Regional Development Funds (FEDER); MINECO (BES2013-063984). CS acknowledges his Postdoctoral research contract funded by the “Instituto de Investigación Sanitaria del Principado de Asturias” (ISPA); University of Granada of “Programa de Doctorado: Medicina Clínica y Salud Pública.”; CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)Resumen
Bacteria-host interactions are mediated by different microbial associated molecular
patterns which are most often surface structures such as, among others,
exopolysaccharides (EPSs). In this work, the capability of two isogenic EPS-producing
Bifidobacterium animalis subsp. lactis strains to modulate the gut microbiota of healthy
mice, was assessed. Each strain produces a different type of polymer; the ropy strain
S89L synthesized a rhamnose-rich, high-molecular weight EPS in highest abundance
than the non-ropy DMS10140 one. BALB/c mice were orally fed for 10 days with
milk-bifidobacterial suspensions and followed afterward for 7 post-intervention days
(wash-out period). The colonic content of mice was collected in several sampling
points to perform a metataxonomic analysis. In addition, the influence of specific
microbial clades, apparently stimulated by the ropy and non-ropy strains, on mouse
plasmatic cytokine levels was investigated through hierarchical association testing.
Analysis of 16S rRNA gene sequences showed that the abundance of Firmicutes
phylum significantly increased 7 days after cessing the treatment with both strains. The
relative abundance of Alloprevotella genus also rose, but after shorter post-treatment
times (3 days for both DMS10140 and S89L strains). Some bacterial clades were
specifically modulated by one or another strain. As such, the non-ropy DMS10140
strain exerted a significant influence on Intestinomonas genus, which increased after
4 post-administration days. On the other hand, feeding with the ropy strain S89L
led to an increase in sequences of Faecalibaculum genus at 4 post-treatment days,
while the abundance of Erysipelotrichaceae and Lactobacillaceae families increased for prolonged times. Association testing revealed that several lactobacilli and bifidobacterial
significantly stimulated by ropy S89L strain were positively associated with the levels
of certain cytokines, including IL-5 and IL-27. These results highlight relevant changes
in mice gut microbiota produced after administration of the ropy S89L strain that were
associated to a potential immune modulation effect.